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Purpose  of  the  research:  Tooth  germ  development  involves  multiple  events,  including  cell  proliferation
and  cell  differentiation.  Connective  tissue  growth  factor  (CTGF/CCN2)  is  a  signaling  protein  involved  in
tooth  germ  development,  and  we  investigated  how  it  is  expressed  and  what  roles  it may  have  in primary
cultures  of  mesenchymal  cells  derived  from  the  developing  tooth  germ.  We  also  examined  the  expression
of  CCN2  in  a  human  odontogenic  myxoﬁbroma,  a benign  tumor  of  odontogenic  mesenchymal  origin,  and
considered  the  possible  roles  of CCN2  in  the  development  of  myxoﬁbromas.
Materials and  methods:  Mesenchymal  cells  of  early  bell-stage  tooth  germs  were  isolated  from  Day-90
bovine  embryos  and  placed  in  primary  culture.  A  resected  specimen  from  a  patient  with  odontogenic
myxoﬁbroma  was  prepared  for immunohistochemical  studies.
Principal results:  The  CCN2  expression  level  in  proliferating  odontogenic  mesenchymal  cells  freshly  iso-
lated  from  the  early  bell  stage  of  developing  bovine  tooth  germs  and  placed  in primary  culture  was  3
times  higher  than  that  in  the  conﬂuent  non-proliferating  cells.  Recombinant  CCN2  signiﬁcantly  increased
the  proliferation  and  type  I collagen  expression  in  odontogenic  mesenchymal  cells  in  primary  culture.
Immunohistochemical  analysis  on  myxoﬁbroma  case  revealed  that  CCN2  was  detectable  in MIB-1,  a cel-
lular  marker  of  proliferation-positive  odontogenic  mesenchymal  cells  adjacent  to capillary  blood  vessels
and  in  the  endothelial  cells  of  the  vessels  in the  tumor.
Major conclusion:  CCN2  signaling  would  inﬂuence  the  proliferation  of  and  extracellular  matrix  production
by  dental  mesenchymal  cells.  Our  results  suggest  that  the  same  mechanisms  of  CCN2  action  toward  dental
mesenchymal  cells  would  also  be  operative  in  the  odontogenic  myxoﬁbroma  microenvironment.
 Japan© 2013
. Introduction
Connective tissue growth factor (CTGF/CCN2) is a heparin-
inding 38-kDa multifunctional cytokine that regulates the
evelopment of organs and tumors by directly inducing cells to
nter the cell cycle and to secrete a variety of cytokines, growth
actors, and extracellular matrix proteins [1–3]. It is a member of
he CCN family of proteins, which is characterized by 4 discrete
rotein modules, in which reside growth factor-binding domains
nd functional motifs for integrin recognition, heparin and pro-
eoglycan binding, and dimerization [1–3]. We  previously reported
hat CCN2 is expressed in odontogenic mesenchyme, odontogenic
∗ Corresponding author. Tel.: +81 86 235 6702; fax: +81 86 235 6704.
E-mail  address: shimotsu@md.okayama-u.ac.jp (T. Shimo).
348-8643/$ – see front matter ©  2013 Japanese Stomatological Society. Published by Els
ttp://dx.doi.org/10.1016/S1348-8643(13)00008-6ese Stomatological Society. Published by Elsevier Ltd. All rights reserved.
epithelium, and dental follicle in the developing tooth germ and
plays important roles in tooth development [4].
Odontogenic myxoﬁbroma represents an uncommon benign
tumor comprising 3–6% of all odontogenic tumors, develops in
the jaws, and shows a high tendency for recurrence [5,6]. They
occur more frequently in individuals between 10 and 40 years
of age, with a slight female predilection (1:1.5 male-to-female)
[7] and almost equally in the maxilla and mandible, with a slight
predilection for the posterior mandible [5]. Odontogenic myxoﬁ-
broma is made up of delicate ﬁbrous connective tissues, and the
spindle-shaped tumor cells are suspended on a network of extra-
cellular matrix (ECM) composed of mucoid ground substance, type
I collagen, ﬁbronectin, tenascin, glycosaminoglycans, and proteo-
glycans [8–10]. Studies on the histopathogenesis of odontogenic
myxoﬁbroma have found a strikingly similarity between it and
hyperplastic undifferentiated mesenchymal tissue of developmen-
tal tooth germs [11–13]. Although the histopathogenic aspect of
evier Ltd. All rights reserved.
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dontogenic myxoﬁbromas has been well studied, no attempts
ave been made to clarify the molecular aspect of the tumorigenesis
iving rise to an odontogenic myxoﬁbroma, because odontogenic
yxoﬁbroma cell lines have not been established.
In the present study, we examined the expression of CCN2
nd its effect on mesenchymal cells in a primary culture system
btained from developing tooth germs, a system that has the advan-
age of closely mimicking the physiological state of cells in vivo
14]. We  found that CCN2 was highly expressed in cells in the pro-
iferative phase and that recombinant CCN2 (rCCN2) stimulated
heir proliferation and the expression of type I collagen. We  esti-
ated that similar regulatory mechanisms of CCN2 as described
bove would also be operative in the microenvironment of odonto-
enic myxoﬁbromas according to the results on the spatiotemporal
xpression pattern of CCN2 in the primary culture system.
.  Materials and methods
.1.  Cell separation and cell culture of odontogenic mesenchymal
ells
Molar tooth germs from 3-month-old embryos were obtained
rom a heifer from a local slaughterhouse. The stages of bovine
mbryogenesis are usually described in terms of longitudinal
ength of the fetuses. The embryos used here were about 15.0 cm
n length (corresponding to approximately Day 90 of gestation).
aw fragments were placed into Hanks balanced-salt solution
GIBCO BRL, Life Technologies Inc., Carlsbad, CA, USA) contain-
ng antibiotics (50 U/ml penicillin, 50 mg/ml  streptomycin, and
.5% fungizone). Early bell-stage tooth germs isolated from Day-
0 bovine embryos were dissected free of surrounding tissues, and
ere brieﬂy exposed to 1.2 U/ml disperse grade II (Boehringer-
annheim, Mannheim, Germany), and then the mesenchymal cells
ere microsurgically separated from the epithelial cell layers. The
esenchyme tissue contained in the dental papilla and dental fol-
icle, which comprised a heterogeneous population of cells, was
inced and incubated in a fresh mixture of 0.25% trypsin (Sigma-
ldrich, St. Louis, MO,  USA) and 0.1% collagenase1 (Sigma-Aldrich)
or 3 h, at which point the tissue was completely digested. The
reshly isolated mesenchymal cells were plated at a density of
 × 104/well in the wells of a 96-well micro-well plate or in cul-
ure dishes at 1 × 106 cells/60-mm dish in Dulbecco’s modiﬁed
agle medium (DMEM) containing 15% fetal bovine serum (FBS)
nd incubated at a 37 ◦C atmosphere of 5% CO2/air.
.2. Immunoﬂuorescence analysis
After having been incubated for 12 h on culture slides as
rimary cultures, the odontogenic mesenchymal cells were
ulse-labeled with ﬂuorescein isothiocyanate (FITC)-conjugated
nti-bromodeoxyuridine (BrdU) during the last 2 h of culture. The
ells were then washed with phosphate-buffered saline (PBS) and
hereafter sequentially ﬁxed for 20 min  with ice-cold acetone. After
aving been washed 3 times with PBS, the ﬁxed cells were incu-
ated at 4 ◦C overnight with anti-CCN2 antibody and thereafter
eacted with rhodamine-conjugated anti-mouse IgG (Santa Cruz
iotechnology, Dallas, TX, USA). The cells were viewed under a
onfocal inverted ﬂuorescence microscope (Zeiss Axiovert 200 M,
öttingen, Germany).
.3.  Preparation of cDNA probesBovine cDNAs for CCN2 (824 bp), type I collagen (856 bp),
nd alkaline phosphatase (ALP) (604 bp) were generated from
otal RNA of bovine fetal tooth germs by use of the reverse
ranscription-polymerase chain reaction (RT-PCR) from totalrnational 11 (2014) 8– 14 9
RNA.  Primer pairs used were the following: 5′-GCCGAATTCTG-
CTGGACGGCTGCGGCTGC-3′ and 5′-GCCCTCGAGGCAGGCACAGGT-
CTTGATGA-3′ for CCN2, 5′-GCCGAATTCTGGATGGATTRAAGGGAC-
AG-3′ and 5′-GCCCTCGAGGAGACCCACAGGRCCTTCTT-3′ for type
I collagen, and 5′-GCCGAATTCACCCTGAAAAATGCCCTGAG-3′ and
5′-GCCCTCGAGCAT ACTCCACATCGGTTCTG-3′ for ALP. The PCR
products were subcloned into the EcoRI and XhoI sites of pBlue-
script II SK (+) and subjected to sequencing for their identiﬁcation.
Each primer pair contained an EcoRI and an XhoI site at the 5′ and
3′ ends, respectively, to facilitate cloning of the PCR product.
High-ﬁdelity Taq polymerase and an ExpandTM High Fidelity
PCR system (Boehringer-Mannheim) were used for PCR ampliﬁca-
tion under the following conditions: denaturation at 94 ◦C for 45 s,
annealing at 52 ◦C for 45 s, and extension at 72 ◦C for 1 min. After
30 PCR cycles, the products were gel-puriﬁed and ligated at the
EcoR1/Xho1site of pBluescript SK (1) vector (Stratagene, La Jolla,
CA, USA). The 1376- to 1915-bp fragment of transforming growth
factor (TGF)-1 was  used as described previously [15]. Independent
clones were sequenced in both directions to verify authenticity and
to determine homology with other species.
2.4. Northern blot analysis
Total  RNA was prepared from quiescent monolayers of mes-
enchymal cells by using TRIZOL reagent (Life Technologies Inc.).
Northern blot analysis was performed by the standard procedure.
Brieﬂy, 10 mg  of total RNA was  denatured by glyoxalation, size-
fractionated by gel electrophoresis in 1% agarose gels at 10 g/lane,
and transferred to a membrane by capillary blotting, as described
previously [16]. Blots were stained with 0.04% methylene blue
to verify that each sample had been transferred efﬁciently. Blots
were hybridized for 16 h to 32P-labeled DNA probes at a concentra-
tion of 2.5 × 106 cpm/ml of hybridization solution containing 50%
formamide, 6× saline sodium citrate (SSC), 1% sodium dodecyl sul-
phate (SDS), 200 mg/ml  sheared denatured salmon sperm DNA, and
10× Denhardt’s reagent. The hybridization temperature was  42 ◦C.
After hybridization, the blots were rinsed several times at room
temperature with 2× SSC and 0.5% SDS; and a ﬁnal high-stringency
rinse was  done with 0.1× SSC and 0.5% SDS at room temperature.
Finally, the blots were exposed to Kodak (Rochester, NY, USA) X-ray
ﬁlms at −70 ◦C.
2.5. Labeling of cell cultures
Cells  in culture dishes were washed with PBS, incubated at 37 ◦C
for 2 h in methionine-free medium (GIBCO BRL), and then pulse-
labeled for 2 h with [35S]methionine (100 mCi/ml, NEN Life Science
Products, Inc., Boston, MA,  USA) with or without 5 mg/ml ascor-
bic acid (Sigma-Aldrich). Following the pulse period, the cells were
washed twice with complete DMEM containing 1% FBS and incu-
bated for 2 h. The media from the 2-h chase period were collected.
Protease inhibitors were added, and media were dialyzed against
3 changes of water.
2.6.  Cell proliferation assay
Cell  proliferation was  determined with a proliferation enzyme-
linked immunoassay BrdU kit according to the manufac-
turer’s protocol (Boehringer-Mannheim). The experiments were
repeated at least 3 times, and triplicate samples were assayed.
Recombinant human CCN2 (rCCN2) was puriﬁed by using
the baculovirus expression system as described previously
[4].
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.7. Histological, histochemical, and immunohistochemical
nalyses of surgically resected samples
Histological staining with hematoxylin/eosin and with phos-
hotungstic acid/hematoxylin was performed on surgical samples
aken from a patient who was a 38-year-old woman with odonto-
enic myxoﬁbroma in the left mandible. Anti-human CCN2 (R&D
ystems, Minneapolis, MN,  USA), anti-human TGF-1 (Santa Cruz
iotechnology, Santa Cruz, CA, USA), and anti-human-MIB1 (Santa
ruz Biotechnology) were used as primary antibodies for the
mmunohistochemical analysis. The immunoreaction was  visu-
lized with 3, 3′-diaminobenzidine (DAB)-containing solution as
escribed previously [17].
.8. Statistical analysis
Data  were analyzed by using the unpaired Student’s t-test for
he analysis of 2 groups, one-way ANOVA with post hoc Bonferroni
nd Dunnett’s test for the analysis of multiple group comparisons,
nd repeated measure ANOVA for the analysis of repeated multiple
roup comparisons. The results were expressed as the mean ± S.D.
nd *p < 0.05 and **p < 0.01 were considered statistically signiﬁcant.
. Results
.1. Expression of CCN2 in proliferative-phase dental
esenchymal cells in primary culture
We explored the molecular regulation of CCN2 expression and
he possible roles of CCN2 in odontogenic mesenchymal cells
reshly isolated from developing bovine tooth germs and put into
rimary culture. First, we  determined whether these dental mes-
nchymal cells expressed CCN2 in the proliferative phase, which
ccurs when the cells are cultured in DMEM containing 15% FBS.
he proliferative dental mesenchymal cells, which had incorpo-
ated BrdU, expressed CCN2 (Fig. 1A). Next, we found that the CCN2
RNA expression level in these proliferating cells in primary cul-
ure was 3 times higher than that in the conﬂuent stationary cells
Fig. 1B). On the other hand, the levels of TGF-, alkaline phos-
hatase, and type I collagen were up-regulated in the stationary
ells from conﬂuent cultures compared with their expression in
he proliferating cells (Fig. 1B).
To examine the effect of CCN2 on the odontogenic mesenchymal
ells, we treated mesenchymal cells in primary cultures for 24 h
ith various amounts of rCCN2 and pulse-labeled them with BrdU
uring the last 2 h of culture. rCCN2 signiﬁcantly stimulated the
roliferation of the cells in a dose-dependent manner (Fig. 1C).
.2.  CCN2 activates the expression of CCN2 and type I collagen in
dontogenic  cells
In  order to elucidate ECM organization of odontogenic mes-
nchymal cells and their related tumors, the bovine mesenchymal
ells were cultured with 5 mg/ml  ascorbic acid. This condition
nduced abundant ECM production (Fig. 2A), which was reﬂected
y the relative intensities of radioactive procollagen bands sepa-
ated on 8–16% Tris-glycine gels (Fig. 2A, arrowhead). We  asked
hen whether CCN2 would have an effect on type I collagen expres-
ion in odontogenic mesenchymal cells. Cultures were treated with
0 ng/ml rCCN2 under the 0.5% serum condition for 1.5–24 h, and
he gene expression was then examined by Northern blot analysis.
s expected, the expression of type I collagen (col I) and ALP was up-
egulated by 3 h and reached a plateau by 6 h (Fig. 2B). Of note, the
ynthesis of CCN2 mRNA was transiently activated by 3 h (Fig. 2B).rnational 11 (2014) 8– 14
3.3.  Macroscopic view and histopathologic examination of the
odontogenic  myxoﬁbroma
The  enucleated tissue of odontogenic myxoﬁbroma at the left
mandible from the patient was  soft and showed white-colored
tumor mass with a mucoid ﬁlm on its surface (Fig. 3A). Hematoxylin
and eosin (HE)-stained sections showed sparsely and randomly
arranged spindle-shaped tumor cells with long cytoplasmic pro-
cesses on a background of abundant myxoid stroma and collagen
ﬁbers in some areas (Fig. 3B). Microscopically, there were tumor
cells loosely arranged in an Alcian blue stain-positive mucoid
matrix composed of glycosaminoglycans, primarily hyaluronic acid
and chondroitin sulfate (Fig. 3C). The tumor showed silver stain-
positive collagen ﬁbers stained in reddish violet (Fig. 3D). CCN2
was highly expressed in the tumor cells (arrowheads) near cap-
illary blood vessels (arrow; Fig. 3E) and in the endothelial cells
of the vessels, as observed under high-power microscopic exam-
ination (p < 0.01, compared with tumor cells situated away from
the vessels). TGF-, which is a potent ﬁbrotic factor responsi-
ble for the synthesis of ECM and an inducer of CCN2, was not
detected in the odontogenic myxoﬁbroma cells situated near the
capillary blood vessels (Fig. 2F). MIB-1, a cellular marker of prolifer-
ation, was  expressed in the nuclei of the odontogenic myxoﬁbroma
cells (arrowheads, Fig. 3F) near the MIB-1-positive capillary blood
vessels (arrows, Fig. 3G). On the other hand, in the region of odon-
togenic myxoﬁbroma without capillary blood vessels (Fig. 3H), an
abundance of Alcian blue stain-positive myxoid stroma (Fig. 3I)
and loose collagen ﬁbers were observed (Fig. 3J). However, CCN2-
(Fig. 3K) and MIB-1 (Fig. 3L)-positive cells were not detected in the
odontogenic myxoﬁbroma cells in which capillary blood vessels
were not present.
4.  Discussion
Our in vitro observations strongly suggest that CCN2 regulated
in a positive manner both cell proliferation and type I collagen pro-
duction in odontogenic mesenchymal cells isolated from bovine
developing tooth germs and placed into primary culture. We  found
that strong expression of CCN2 correlated well with the prolifera-
tion phase of those odontogenic mesenchymal cells and that once
the cultures had become conﬂuent, CCN2 expression decreased.
We also showed that CCN2 positively regulated the proliferation of
odontogenic cells in a dose-dependent manner. These data are con-
sistent with our previous in vivo study showing that E14 mice tooth
germs injected with CCN2 neutralizing antibodies were smaller in
overall size than those in the controls and that cell proliferation
was severely reduced [4]. It should be noted that the expression
levels of TGF- and type I collagen were relatively low during cell
proliferation but were up-regulated once the cultures had reached
conﬂuence. There are numerous reports in the literature conﬁrming
that treatment with TGF- increases the production of type I col-
lagen in other cell types by acting directly or via up-regulation of
CCN2 [18,19]. More studies are needed to elucidate the regulation
of CCN2 expression in the proliferating phase in the odontogenic
mesenchymal cells in both TGF--dependent and -independent
manners.
Myxoﬁbroma has been considered to be of odontogenic origin
mainly based on the histological ﬁndings of the randomly oriented
arrangement of myxomatous tumor cells. While there were no
missing or impacted teeth in the myxoﬁbroma region of the patient,
histopathological examination of the surgical specimens revealed
that the myxoﬁbroma contained cellular components resembling
those of the odontogenic mesenchymal tissue, odontogenic epithe-
lium, and dental follicle [12]. These results showing the presence
of CCN2 protein in the tumor may  also be consistent with our
T. Shimo et al. / Oral Science International 11 (2014) 8– 14 11
Fig. 1. Immunohistochemical and Northern blot analysis of proliferative phase of developing dental mesenchymal cells in primary culture. (A and B) Bovine dental mesenchy-
mal  cells were inoculated at a density of 1 × 106/dish into 6-cm dishes and cultured in Dulbecco’s modiﬁed eagle medium (DMEM) containing 15% fetal bovine serum (FBS)
for 48 h. The medium was changed to 3 ml  of DMEM containing 15% FBS, and the cells were cultured for 12 h after which time they were actively proliferating (proliferative).
After 36 h, the medium was  replaced with 3 ml  of DMEM containing 15% FBS, and the cells were cultured for 12 h until they reached conﬂuence (stationary). Proliferating
bovine dental mesenchymal cells were exposed to 5-bromo-2-deoxyuridine (BrdU) and then examined for ﬂuorescence of ﬂuorescein isothiocyanate (FITC) and rhodamine
(CCN2) (A). Proliferating cells and those in the stationary phase were examined by Northern blotting for their expression of CCN2, transforming growth factor (TGF)-,
a nalyze
r niﬁca
p
e
l
tlkaline phosphatase (ALP), and type I collagen (Coll-1). The gene expression was a
ecombinant CCN2 on the proliferation of dental mesenchymal cells. * Statistical sigrevious report stating that CCN2 transcripts are spatiotemporally
xpressed in the odontogenic mesenchyme, odontogenic epithe-
ium, and dental follicle in developing tooth germs [4]. However,
he density of odontogenic epithelial cells within the odontogenicd by computer-assisted densitometric analysis of band intensities (B). (C) Effect of
nce deﬁned as p < 0.05.mesenchymal structure like tumor is usually very low, and the
occurrence of odontogenic epithelial nests has been reported to be 0
or 10.7% [5,20]. In the present case, odontogenic epithelial nest cells
were not present in the tumor tissue, and the amount of collagen
12 T.  Shimo et al. / Oral Science International 11 (2014) 8– 14
Fig. 2. Procollagen expression and the effect of CCN2 on odontogenic mesenchymal cells. (A) Morphology of odontogenic mesenchymal cells in primary culture with or without
ascorbic acid (upper panel). Aliquots of culture medium from [35S] methionine-labeled odontogenic mesenchymal cells with or without ascorbic acid were analyzed on 8–16%
T  reduc
r hosph
b cance 
i
g
t
o
p
p
mris-glycine gel sodium dodecyl sulphate-polyacrylamide gel electrophoresis under
ecombinant CCN2. Expression levels of CCN2, type I collagen (coll I), and alkaline p
y  computer-assisted densitometric analysis of band intensities. * Statistical signiﬁ
n the mucoid stroma was prominent. Studies on the histopatho-
enesis of odontogenic myxoﬁbroma have found such ﬁbromas
o most closely resemble the primitive mesenchymal structure of
dontogenic mesenchyme in the developing tooth germ. Cells in
rimary culture have an advantage of very closely mimicking the
hysiological state of cells, and rodent odontogenic mesenchy-
al cells are conventionally used for in vitro studies. However,ing conditions (lower panel). (B) Modulation of gene expression by treatment with
atase (ALP) were analyzed by Northern blotting. The gene expression was assessed
deﬁned as p < 0.05.
preservation of primitive cell structure, cell-speciﬁc metabolism,
and cell-cell interactions in vitro are often limited by the restricted
number of cells available. On the other hand, the primary culture
system using bovine odontogenic mesenchymal cells has a great
advantage for stability and maintenance of the primitive struc-
ture, because a high-grade and large number of freshly isolated
cells is available without any passage. We thus suggest that this
T. Shimo et al. / Oral Science International 11 (2014) 8– 14 13
Fig. 3. Histopathological and immunohistochemical examinations of odontogenic myxoﬁbroma tissue from a patient. (A) Gross morphology of the odontogenic myxoﬁbroma.
(B–F) Hematoxylin and eosin (HE)-stained histological section; (B) Alcian blue staining for glycosaminoglycans and proteoglycans; (C) silver staining for collagen ﬁbers; (D)
immunohistochemical staining for CCN2 (E) and TGF-1; (F) in an area with capillary blood vessels in a section of odontogenic myxoﬁbroma were performed. CCN2 was highly
expressed in the tumor cells near capillary blood vessels compared with the expression in tumor cells located always from the vessels (p < 0.01). Arrowheads: CCN2-positive
t IB-1
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m
c
m
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n
oumor cells. Arrows: capillary blood vessels. (G) Immunohistochemical staining for M
esults  are shown for HE staining (H), Alcian blue staining (I), silver staining (J), an
yxoﬁbroma in an area lacking capillary blood vessels.
ulture system is a potential tool for investigating the primitive
esenchymal origin of odontogenic myxoﬁbromas. However, fur-
her studies are needed to examine the expression of CCN2 in other
dontogenic tumors including ameloblastic ﬁbromas, which show
 similar histological feature of their mesenchymal component
21].
Compelling data implicate angiogenesis and tumor-associated
eovascularization as a central pathogenic step in the process
f tumor growth and invasion [22–24]. Our immunohistological. Arrowheads: tumor cells. Arrows: capillary blood vessels. Scale bar: 500 m. (H–L)
unohistochemical staining for CCN2 (K) and MIB-1 (L) in sections of odontogenic
examination of this odontogenic myxoﬁbroma clearly revealed that
CCN2 was highly expressed in microvascular endothelial cells and
in the surrounding tumor cells. Keeping the potent pro-angiogenic
activity of CCN2 and CCN2 gene regulation in mind [25,26], it is
thus conceivable that CCN2 could contribute to the growth of odon-
togenic myxoﬁbromas by acting in both autocrine and paracrine
fashions. More importantly, the increase in cellularity of the tumor
tissue around the blood vessels might be essentially dependent on
the blood supply. This idea is supported by our histopathological
14 T.  Shimo et al. / Oral Science Inte
Fig. 4. Hypothetical roles of CCN2 in the regulation of the microenvironment of
an odontogenic myxoﬁbroma. Microvascular endothelial cells secrete CCN2 and
growth factors, which are the primary stimulators of proliferation of odontogenic
myxoﬁbroma  cells. In the proliferation phase of an odontogenic myxoﬁbroma, cells
at a short distance from the capillary blood vessels (a) are induced to produce CCN2,
which leads to increased proliferation and collagen ﬁber production in an autocrine
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[anner.  On the other hand, odontogenic myxoﬁbroma cells at a long distance from
he capillary blood vessels (b) lack stimulation by endothelium-derived CCN2 and
hus produce fewer collagen ﬁbers. CF, collagen ﬁber.
xamination showing that there were MIB-1-positive (prolifer-
ting) tumor cells adjacent to the CCN2-positive microvascular
ndothelial cells and that many fewer tumor cells were distributed
n the regions with less vascularization (Fig. 4).
Although TGF- enhances generally type I collagen produc-
ion in the mesenchymal cells by up-regulation of CCN2, in the
resent study, the expression of TGF- in odontogenic myxoﬁ-
roma was not correlated with CCN2 expression and collagen ﬁber
roduction. It may  be likely that the mis-regulation of TGF--CCN2
ignaling pathway is one of the characteristic molecular events
n tumorigenesis. One of the mechanisms by which odontogenic
yxoﬁbroma cells express CCN2 may  be via mitogen signals and
xternal stimuli including endothelin-1 from the capillary blood
essels [27] and, matrix-associated gene induction via ETA recep-
ors acting independently of TGF- signaling pathway [28,29].
urther study is needed for clariﬁcation of the mechanism of the
CN2 gene expression in the odontogenic myxoﬁbroma microen-
ironment.
. Conclusions
Here we unveiled a mechanism by which activation of CCN2
ignaling would inﬂuence the cell proliferation and ECM synthe-
is in mesenchymal cells in a primary culture system derived from
eveloping tooth germs. These in vitro data allow us to speculate
hat the same mechanisms of CCN2 action toward odontogenic
esenchymal cells are also operative in the odontogenic myx-
ﬁbroma microenvironment. We  propose that CCN2 produced by
umor cells located near the capillary blood vessels could establish
he microenvironment for the growth of odontogenic myxoﬁbro-
as, although how CCN2 modulates the extracellular molecular
etwork involved in the development of these tumors remains to
e investigated.onﬂict of interest
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